Division of Gynecology
Department Quality Director
Department of Obstetrics and Gynecology
View Dr. Byun’s UF Health Profile
Dr. Sharon Byun joins the OB-GYN faculty after five years at the University of Pennsylvania where she was Assistant Professor of Clinical Obstetrics and Gynecology in the General OB-GYN Division. A Philadelphia native, she received her medical degree from Temple University in 2000 and completed her residency in OB-GYN at Thomas Jefferson University in Philadelphia in 2004 where she served as the administrative chief resident.
Dr. Byun brings significant laparoscopic and robotic experience, with her primary professional interests in general gynecology, minimally invasive surgery including Da Vinci Robotic Surgery, and gynecologic care of breast cancer survivors including women with hereditary BRCA 1 and 2 gene mutations. She is also skilled in operative vaginal delivery with forceps and is interested in preserving resident training of this valuable skill.
Throughout her career, Dr. Byun has been recognized as an excellent research and medical educator. At Temple, she received the Scholar’s Award for demonstration of outstanding interest and aptitude in OB-GYN. Upon graduation from residency, Dr. Byun received Resident of the Year, the Howard Lees Kent Memorial Prize for Outstanding Scholarship, and Best Resident Research Awards. She places high priority on resident education and received the CREOG Faculty Teaching Award for Excellence in Resident Education in 2009 at Penn.
Dr. Byun is board certified in obstetrics and gynecology and is a Fellow of the American College of Obstetricians and Gynecologists. She is a member of the UF College of Medicine’s Quality and Safety Committee as well as chair of the department’s committee. She has lectured on her interests in robotic gynecologic surgery and surveillance of women on Tamoxifen. She has also published on topics including the role of robotic surgery in urogynecologic surgery, comparison of abdominal and vaginal hysterectomy, ovarian preservation in Stage I low grade endometrial stromal sarcomas, and post term pregnancy.